Tag - pharmaceuticals

 
Menu
Search
 
November 22, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan's pharmaceutical shares have gained 10% since the start of July through last week.
BUSINESS / Companies
Aug 27, 2024
Japan's pharmaceutical stocks surge to record highs after market rout
The firms' market performance suggest investors favor defensive shares amid concern that global economic growth will slow.
Health workers and patients in a ward for women infected with mpox at a hospital in Bujumbura, Burundi, on Thursday.
WORLD / Science & Health
Aug 23, 2024
WHO says partners can start talks to buy mpox vaccines before its approval
Traditionally, organizations like Gavi, which helps lower-income countries buy vaccines, can only start purchasing shots once they have approval from the WHO.
U.K. authorities have approved lecanemab, a novel Alzheimer's drug developed by Eisai, making Britain the first country in Europe to greenlight the drug.
JAPAN
Aug 23, 2024
Britain OKs Eisai's novel Alzheimer's drug lecanemab
The United Kingdom is the first country in Europe to greenlight the drug.
Health minister Keizo Takemi fields questions from reporters in March after a Cabinet meeting to deal with health problems caused by Kobayashi Pharmaceutical's beni kōji red yeast rice supplements.
JAPAN / Science & Health
Aug 14, 2024
Health Minister Keizo Takemi on how to improve Japan's health care system
Digitalization, hiring high-skilled foreign workers and increasing wages are among the steps that Japan could take.
In the past 11 months, health minister Keizo Takemi has been charting his own path, seeking to make Japan's health care policies more global and digitalized.
JAPAN / Science & Health
Aug 14, 2024
Global mindset crucial for reform of Japan's health care, minister says
International strategies and domestic health care reform are inextricably linked, says health minister Keizo Takemi.
Former Kobayashi Pharmaceutical President Akihiro Kobayashi (second from right) speaks during a news conference in Osaka on Aug. 8 along with President Satoshi Yamane (third from right).
JAPAN / Society
Aug 14, 2024
Kobayashi Pharma fails to report 11 more suspected deaths
The 11 cases had been classified into a wrong category in the process of sorting out the inquiries made to its call center.
A petrochemical plant in China. Asia's producers face the toughest outlook, with oversupply likely to persist.
BUSINESS / Companies / ANALYSIS
Aug 9, 2024
Petrochemical makers enter survival mode amid global glut
Major petrochemical producers in Asia and Europe are selling assets, shutting older plants, and retrofitting facilities.
Former Kobayashi Pharmaceutical President Akihiro Kobayashi (right) and Satoshi Yamane, the new president, bow in apology over health problems caused by its beni kōji products, during a news conference in the city of Osaka on Thursday.
JAPAN / Science & Health
Aug 8, 2024
Kobayashi Pharma to withdraw from beni kōji product segment
The firm said it would offer compensation to those who suffered health problems linked to their products and prevent a recurrence of the incident.
The Mefeego pill pack
JAPAN / Society
Aug 5, 2024
Japan's health ministry considers wider availability for abortion pill
Currently, the medication can only be administered in hospitals with inpatient capabilities.
A health ministry panel has approved Eli Lilly's donanemab drug for Alzheimer's patients.
JAPAN / Science & Health
Aug 2, 2024
Japan's health ministry set to approve second Alzheimer's drug
Donanemab, developed by U.S. pharmaceutical firm Eli Lilly, has been backed by a ministry panel.
As of March 2023, there were 86 medicines that had been approved in Europe or the United States but remained unavailable in Japan.
JAPAN / Science & Health
Jul 30, 2024
Japan unveils plan to improve access to foreign drugs
The road map to address what is known as "drug loss" envisions that development of in-demand medicines will start by April 2026.
Leqembi, which was developed by U.S. multinational Biogen and Japanese-based Eisai, is the brand name of an active substance called lecanemab, which is used to treat adults with mild memory and cognitive problems resulting from the early stages of the common type of dementia.
JAPAN / Science & Health
Jul 27, 2024
European medicines watchdog rejects Eisai's new Alzheimer's drug
The watchdog said the risks of side effects, including potential brain bleeding, outweighed the benefits.
Amazon has launched an online service enabling customers in Japan to purchase prescription medications without having to visit physical pharmacies.
BUSINESS / Companies
Jul 24, 2024
Amazon Pharmacy goes live in Japan
Through the new service, Japanese consumers will be able to obtain medications without having to visit physical pharmacies.
As of Sunday, Kobayashi Pharmaceutical reported 279 deaths and 2,274 hospital visits due to health issues related to its beni kōji supplements, among which 461 required hospitalization.
JAPAN / Science & Health
Jul 23, 2024
Kobayashi Pharma's president and chairperson resign over health scandal
For the first time in its history, someone outside of the Osaka-based drugmaker's founding family will become its president.
A 25-miligram bottle of muscle relaxant was discovered missing at Osaka City General Hospital on Friday when hospital officials performed a routine check of a safe that stores pharmaceuticals.
JAPAN / Crime & Legal
Jul 15, 2024
Muscle relaxant goes missing at Osaka hospital
The 25-miligram bottle of the drug, equivalent to 1½ times the lethal dose for an adult, was discovered missing during a routine check on Friday.
Kobayashi Pharmaceutical President Akihiro Kobayashi and others at a news conference in Osaka in March.
JAPAN / Society
Jul 3, 2024
492 people hospitalized for 'beni kōji' supplements
Kobayashi Pharmaceutical says it has received consultations about a further 170 deaths possibly linked to its supplements.
Health ministry officials enter Kobayashi Pharmaceutical's plant in the city of Osaka on March 30.
JAPAN / Society
Jun 28, 2024
Dozens more deaths may be linked to Kobayashi Pharmaceutical's supplements
The ministry has instructed Kobayashi Pharmaceutical to create a plan to carry out a probe into the causal relationships between the deaths and their products.
Researchers are still years away from understanding the actual impact of AI on addressing human diseases. But given the speed with which the technology is evolving, its increasingly looking like the impact could be vast.
COMMENTARY / World
Jun 12, 2024
Inventing medicines is one of the most exciting uses of AI
AlphaFold has advanced significantly since its earlier version, offering static images of protein interactions.
Naoki Okamura, chief executive officer of Astellas Pharma, speaks during an interview in Tokyo on Monday.
BUSINESS / Companies
Jun 11, 2024
Astellas seeks green light for eye drug Izervay in Europe and Japan
The drugmaker is in discussions with Japanese regulators about whether clinical trials for local patients are needed, Chief Executive Naoki Okamura said.
Chief Cabinet Secretary Yoshimasa Hayashi (left) addresses a meeting of ministers involved in compiling a policy to revise the system for foods with function claims, held at the Prime Minister's Office on Friday.
JAPAN
May 31, 2024
Japan to overhaul foods with function claims system
The overhaul plan will make it mandatory for companies to promptly report health issues related to foods with function claims to authorities to prevent spread.
Two of America’s biggest debt holders are dumping Treasurys
The U.S. Treasury building in Washington. Investors in Japan and China sold a pile of U.S. debt in the last quarter, just before the U.S. presidential election.
Ishiba aggravates his own political failures with diplomatic faux pas
Prime Minster Shigeru Ishiba is greeted at the APEC summit in Lima by Canadian Prime Minister Justin Trudeau on Friday. The Japanese leader was criticized for remaining seated while meeting several world leaders at the event.
Japan's 3.31 million visitors in October set monthly record
Kiyomizu Temple in Kyoto in December 2023. Famous autumn leaf colors contributed to increased tourism demand last month from many markets across Asia, Europe and North America, the Japan National Tourism Organization has said.
Japan ranks last in romance satisfaction for second straight year
In a survey of 31 countries, Japan ranked last in terms of those who felt loved, with just 51% of respondents saying so.
Ruling coalition and DPP strike last-minute deal over economic policy
DPP policy chief Makoto Mahaguchi speaks at the party's policy gathering in Tokyo on Wednesday.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.
Haruki Murakami's 'The City and Its Uncertain Walls' gives deep deja vu
For “The City and Its Uncertain Walls,” translated into English by Philip Gabriel, Haruki Murakami confronts the ghosts who won't leave him alone.
Japanese expats in Asia find community through rugby
The Taiwan Fivewoods celebrate their victory at the 2023 Asian Japanese Rugby Cup in December of last year.
In Fukushima, a weekend of prose, poetry and translation
Aomori-based writer JJ Carter presented on tabletop gaming as creative inspiration for building characters and narratives.
For Dr. Nakamats, aging is just experience in action
Though he didn't win the recent gubernatorial election in Tokyo, the 96-year-old Dr. Nakamats' run was seen as inspirational in Japan's aging society.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

SWCC keeps changing with keyword ‘new challenges’
SWCC keeps changing with keyword ‘new challenges’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER